Stock Earnings

Question 1

Vertex Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Vertex Pharmaceuticals Inc'in toplam varlıkları $22,533 olup, net loss $-535'dir.

Question 2

VRTX'ün temel finansal oranları nelerdir?

Accepted Answer

Vertex Pharmaceuticals Inc'in cari oranı 3.68, net kâr marjı -4.85, hisse başına satış $42.72'dir.

Question 3

Vertex Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Vertex Pharmaceuticals Inc largest revenue segment is Other, at a revenue of 771,500,000 in the most earnings release.For geography, Other Collaborative and Royalty is the primary market for Vertex Pharmaceuticals Inc, at a revenue of 1,000,000.

Question 4

Vertex Pharmaceuticals Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Vertex Pharmaceuticals Inc'in net loss $-535'dir.

Question 5

Vertex Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Vertex Pharmaceuticals Inc'in yükümlülüğü 6,123'dir.

Question 6

Vertex Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Vertex Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 256.94'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	11,723	11,020	9,869	8,930	7,574	6,205
Revenue Growth (YoY)	10%	12%	11%	18%	22%	49%
Cost of Revenue	1,608	1,530	1,262	1,080	904	736
Gross Profit	10,114	9,489	8,607	7,850	6,670	5,469
Selling, General & Admin	1,643	1,464	1,136	944	840	770
Research & Development	3,934	3,630	3,162	2,527	3,051	1,829
Operating Expenses	5,578	5,094	4,247	3,414	3,888	2,613
Other Non Operating Income (Expenses)	-21	-76	-15	-15	-12	160
Pretax Income	4,448	248	4,379	4,232	2,730	3,116
Income Tax Expense	773	784	760	910	388	405
Net Income	3,675	-535	3,619	3,322	2,342	2,711
Net Income Growth	-867%	-114.99%	9%	42%	-14%	131%
Shares Outstanding (Diluted)	257.6	257.9	260.5	259.1	259.9	263.39
Shares Change (YoY)	-1%	-1%	1%	0%	-1%	1%
EPS (Diluted)	14.26	-2.08	13.89	12.82	9.01	10.29
EPS Growth	-878.99%	-114.99%	8%	42%	-12%	128%
Free Cash Flow	3,337	-978	3,278	3,925	2,408	2,993
Free Cash Flow Per Share	12.95	-3.79	12.58	15.14	9.26	11.36
Gross Margin	86.27%	86.1%	87.21%	87.9%	88.06%	88.13%
Operating Margin	38.69%	39.88%	44.16%	49.66%	36.73%	46.02%
Profit Margin	31.34%	-4.85%	36.67%	37.2%	30.92%	43.69%
Free Cash Flow Margin	28.46%	-8.87%	33.21%	43.95%	31.79%	48.23%
EBITDA	4,736	4,602	4,540	4,583	2,907	2,965
EBITDA Margin	40.39%	41.76%	46%	51.32%	38.38%	47.78%
D&A For EBITDA	200	207	181	148	125	109
EBIT	4,536	4,395	4,359	4,435	2,782	2,856
EBIT Margin	38.69%	39.88%	44.16%	49.66%	36.73%	46.02%
Effective Tax Rate	17.37%	316.12%	17.35%	21.5%	14.21%	12.99%

Vertex Pharmaceuticals Inc (VRTX) Price

VRTX Stock Price Chart

VRTX Income

Follow-Up Questions